Lisa Schrade, PharmD:Extended half-life products affecting patients’ quality of life: It is definitely positive in regard to how it compares to the standard half-life products. However, sometimes that dosing interval changes only by 1, maybe 2, days. It really all depends on which pr...
A new cohort, 1D, will begin in the IOV-COM-202 trial in solid tumors to investigate lifileucel in combination with nivolumab and relatlimab in patients with frontline advanced melanoma, representing another potential best-in-class frontline alternative for physicians and patients in the...
For each of the past 19 years, the American Montessori Society has chosen to recognize one Montessorian as an AMS Living Legacy. Recipients are honored at ... S Loveless - 《Montessori Life A Publication of the American Montessori Society》 被引量: 1发表: 2012年 Continuing evidence for poore...